Sequana Medical is a Swiss medical device company providing implantable pump systems to manage fluid balance within the body. This system is designed to move excess fluid to the bladder, where it is passed naturally from the body through normal urination. Sequana Medical’s first product, the Alfapump System, is an innovative solution for the management of ascites. Ascites is a fluid that collects in the abdominal cavity in people with advanced liver disease, certain cancers, or congestive heart failure. Alfapump System was the first and only system for the automatic and continual removal of ascites. Sequana Medical was founded in 2006 and is based in Zurich, Switzerland.
TIS helps CFOs, Treasurers, and Finance teams transform their global cash flow, liquidity, and payment functions. Since 2010, our award-winning cloud platform and best-in-class service model have empowered the entire office of the CFO to collaborate more effectively and attain maximum efficiency, automation, and control. By streamlining connectivity between our customers’ back-office systems and their worldwide banks, vendors, and business partners, TIS enables users to achieve superior performance in key areas surrounding cash forecasting, working capital, outbound payments, financial messaging, fraud prevention, payment compliance, and more. With over 11,000 banking options, $80 billion in daily cash managed, and $2.5 trillion in annual transaction volume, TIS has a proven track record of combining our unparalleled market expertise with tailored client and community feedback to drive digital transformation for companies of all sizes and industries. As a result, hundreds of organizations and thousands of practitioners rely on TIS daily to gain strategic advantage, monetize data, improve operational efficiency, and better manage risk. For more information, visit tispayments.com and begin reimagining your approach to global cash flow, liquidity, and payments.
Pyramid is what’s next in analytics. Our unified decision intelligence platform delivers insights for everyone to make faster, more informed decisions. It provides direct access to any data, enables governed self-service for any person, and serves any analytics need in a no-code environment. The Pyramid Decision Intelligence Platform uniquely combines Data Prep, Business Analytics, and Data Science in a single environment with AI guidance, reducing cost and complexity while accelerating growth and innovation. The Pyramid Platform enables a strategic, organization-wide approach to Business Intelligence and Analytics, from the simple to the sophisticated. Learn more www.pyramidanalytics.com
PolyPid is a development stage company that has developed a platform technology for the healthcare industry that enables a controlled and prolonged release of any active pharmaceutical ingredients (API). PolyPid’s technology combines polymers and lipids, enabling small-and-large API entrapment in degradation and hydration protected environments, regardless of their chemical or physical characteristics. PolyPid allows the release of the API from the reservoir at pre-determined rates of up to several months, with a constant release rate (zero-order kinetics). The flexibility of this innovative technology enables local administration of compounds across numerous therapeutic classes for several applications.
VectivBio is a clinical-stage biotechnology company bringing transformational medicines to patients with serious rare diseases. They are committed to pursuing rare diseases with well-defined biology that can be targeted with best-in-disease therapies that have the potential to meaningfully transform and improve the lives of patients and their families, not just provide an incremental improvement or benefit over the standard-of-care. It was founded as a spinout from Therachon, a biotechnology company acquired by Pfizer for its program in achondroplasia. VectivBio was incorporated in 2019 and is based in Basel, Switzerland.
Moove is a mobility fintech that provides revenue-based vehicle financing to mobility entrepreneurs, democratizing vehicle ownership across Africa. The company embeds its alternative credit-scoring technology onto ride-hailing, logistics, and last-mile/instant delivery platforms, which allows access to proprietary performance and revenue analytics of mobility entrepreneurs to underwrite loans.
Scandit is a technology platform for mobile computer vision and augmented reality (AR) solutions for enterprises. The company software brings unrivaled scanning performance to any app on any camera-equipped smart device, from smartphones to wearables to drones and robots - to read barcodes, recognize text and objects, and display real-time information as AR overlays. It helps consumers and employees find things on store shelves with their smartphones, and as things become more contactless. Organizations in retail, transport, logistics, and manufacturing use Scandit to power apps such as mobile shopping, self-checkout, inventory management, proof of delivery, and asset tracking. Use cases in healthcare include tracking patients, medication, specimens, and supplies. Scandit solutions take cost and time out of operations and improve employee and customer satisfaction. Clients include 7-Eleven, Alaska Airlines, Carrefour, Hermes, Johns Hopkins Hospital, La Poste, Levi Strauss & Co, Mount Sinai Hospital, Sephora, and Toyota.
Numan is a digital platform for men’s health that provides direct online access to medical professionals, prescription medication, at-home blood testing, and holistic health advice. Offering a digital-first service, the company provides men with treatments for erectile dysfunction, premature ejaculation, hair loss, and nutritional deficiencies on its proprietary, integrated-care platform. Numan provides men with the tools they need to improve their health and wellbeing and confronts the gender gap when it comes to healthcare-seeking behaviors.
Numa, operating under the brand COSI Hospitality GmbH, specializes in designing, developing, and managing lifestyle apartments tailored for weekend getaways, business trips, and temporary living arrangements. Based in Berlin, Germany, the company focuses on providing uniquely designed accommodations that cater to the needs of modern travelers. In addition to its hospitality services, Numa builds a technology and data platform that aims to enhance the integration of hospitality services, real estate, and guest experiences, thereby creating a seamless and innovative experience for users.
FintechOS is the leader in fintech enablement, with a mission to make fintech innovation available to every company. The FintechOS platform simplifies and accelerates the launching, servicing, and expansion of financial products and services, helping businesses recognize value five to 10 times sooner than with other approaches: with FintechOS, companies can get up and running with new financial solutions in as little as 12 weeks. Unlike others, FintechOS breaks data free from the core, enabling the creation of personalized and differentiated products and customer journeys at scale. FintechOS connects with any ecosystem tech or service – financial and non-financial – and can plug anywhere in the tech stack, working with existing and legacy tech that companies want to keep. A global employer co-headquartered in London and New York, FintechOS customers range from globally strategic companies like Groupe Société Générale, Admiral Group, and BPCE Oney, to game-changing players like Vibrant, eMag, and Howden. Its partners include both niche consulting agencies and global consulting firms and systems integrators. These capabilities free our customers to tailor products, services, and interactions to a segment of one, increase ROI and decrease time-to-market.
VOI Technology is a micro-mobility startup that provides electric scooters for last-mile transportation. They create a system of electrically powered scooters around urban centers to provide a way to commute while helping people to reduce their carbon footprint and cities to have a more sustainable transportation network.
Biophytis is a clinical-stage biotechnology company focused on the development of therapeutics that slow the degenerative processes associated with aging and improve functional outcomes for patients suffering from age-related diseases. Their goal is to become a leader in the emerging field of aging science by delivering life-changing therapies to the growing number of patients in need that have limited or no treatment options. To accomplish this goal, they have assembled an experienced and skilled group of industry professionals, scientists, clinicians and key opinion leaders from leading industry and academic institutions from around the world.
Recharge is a B2C prepaid payments platform operating multiple digital storefronts including Recharge.com and Startselect.com. With its mission to 'Make Prepaid Easy,' the company distributes over 16,000 different types of digital vouchers and prepaid products, for large prepaid categories such as e-gift, shopping, and gaming cards, prepaid money cards, and international mobile and cross-border top ups. Through providing consumers with simple access to these Prepaid Payment Products they are driving a new era of accessibility to financial empowerment, giving consumers greater spending control and flexibility on their terms. Founded in 2010, today they operate in over 180 markets whilst headquartered in Amsterdam. The company is backed by Prime Ventures, Smartfin, Committed Capital and BlackRock raising ~$75M in Series A & B rounds to date.
EGYM is a global fitness technology company that provides fitness and health facilities with intelligent workout solutions built on a robust ecosystem of connected gym equipment and software. EGYM empowers gym operators to deliver a comprehensive workout experience through its smart gym equipment and digital solutions to support their members' fitness journey and provide data-based guidance to help them stay motivated and achieve their goal of a healthier life with improved physical and mental wellness. Because there is one thing EGYM is convinced of member success means gym success.
Refurbed operates as an online marketplace for refurbished products. It sells renewed phones, laptops, and tablets up to 40% cheaper and 100% more environmentally friendly than their brand-new, store-bought counterparts. Refurbed devices are renewed through a 40-step process, making them look new and function like new. On top of that, each device comes with at least a 12-month guarantee. The company was founded in 2017 and is headquartered in Vienna, Austria.
Expertlead is a HR tech company specialized in the recruitment and technical qualification of IT experts. The company's unique selling proposition is the exceptional combination of technology and community know-how that enables it to find, assess and hire the right IT experts. Technical skills of IT candidates are assessed through a special peer-to-peer interview process, where Expertlead uses the collective intelligence of the global tech community to check the quality of applicants across different programming languages. In combination with an innovative recruiting software, Expertlead can offer a holistic solution in tech recruiting. Over the past years, the company has built up a global community of highly qualified tech freelancers in the fields of software development, data science, product/project management, solution architecture and UX/UI design.
Motus GI Holdings, Inc. is a medical technology company, with subsidiaries in the U.S. and Israel, dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The Company is focused on the development and commercialization of the Pure-Vu® System to improve the colonoscopy experience and assist in the early detection and prevention of colorectal cancer and other diseases of the rectum and colon.
Calliditas Therapeutics AB is a specialty pharmaceutical company based in Stockholm, Sweden. It is focused on developing high quality pharmaceutical products for patients with a significant unmet medical need in niche indications, in which Calliditas can partially or completely participate in the commercialization efforts. Calliditas is focused on the development and commercialization of the product candidate Nefecon, a unique two step formulation optimized to combine a time lag effect with a concentrated release of the active substance budesonide, within a designated target area. This patented, locally acting formulation is intended for treatment of patients with the inflammatory renal disease IgA nephropathy (IgAN). Calliditas is running a global Phase 3 study within IgAN and aims to commercialize Nefecon in the United States.
Grover provides an online platform for renting tech products through monthly subscriptions. This service includes a wide range of over 3,000 tech products such as smartphones, laptops, VR gear, wearables, and smart home appliances. Grover's business model focuses on the circular economy, refurbishing and re-circulating returned products to maximize their lifespan and reduce e-waste. Each product is typically rented out to multiple users before being fully retired. The company operates in several markets, including the U.S., Germany, Austria, the Netherlands, and Spain.
PlusDental is a fast-growing Digital Health Startup in the area of digital orthodontics operating from Berlin/Germany. We treat cosmetic cases of malocclusion (teeth straightening) through our innovative treatment approach using clear aligners. We are a fast growing team of business people and dentists/orthodontists aiming at revolutionising the treatment of aesthetic orthodontics in Europe. Clear aligners are a fast-growing market segment world wide and we want to help more customers to use the benefits of this easy to use and versatile treatment method. We make treatments much more convenient and affordable for our customers through the use and development of cutting-edge technology.
Recharge is a B2C prepaid payments platform operating multiple digital storefronts including Recharge.com and Startselect.com. With its mission to 'Make Prepaid Easy,' the company distributes over 16,000 different types of digital vouchers and prepaid products, for large prepaid categories such as e-gift, shopping, and gaming cards, prepaid money cards, and international mobile and cross-border top ups. Through providing consumers with simple access to these Prepaid Payment Products they are driving a new era of accessibility to financial empowerment, giving consumers greater spending control and flexibility on their terms. Founded in 2010, today they operate in over 180 markets whilst headquartered in Amsterdam. The company is backed by Prime Ventures, Smartfin, Committed Capital and BlackRock raising ~$75M in Series A & B rounds to date.
TME Pharma is a biopharmaceutical company, develops biostable aptamers and substances based on mirror image nucleic acids. Its Spiegelmer is a mirror image oligonucleotide therapeutic for the pharmacologically relevant target. The company has a strategic alliance with Pfizer, Inc. NOXXON Pharma AG was founded in 1997 and is based in Berlin, Germany.
Numa, operating under the brand COSI Hospitality GmbH, specializes in designing, developing, and managing lifestyle apartments tailored for weekend getaways, business trips, and temporary living arrangements. Based in Berlin, Germany, the company focuses on providing uniquely designed accommodations that cater to the needs of modern travelers. In addition to its hospitality services, Numa builds a technology and data platform that aims to enhance the integration of hospitality services, real estate, and guest experiences, thereby creating a seamless and innovative experience for users.
Essor focuses on business tasks such as acquisitions, investments, sourcing, and marketing, allowing third-party seller brands from diverse marketplaces to reach global scale growth. Essor’s brand portfolio today includes a broad range of rapidly growing health & wellness and lifestyle brands like Boka, ZitSticka, Puracy, OTOTO Design, FreshCap, Iron Flask, Fullstar, numnum, Key Nutrients, and Viking Revolution that are sold on Amazon, Direct to Consumer channels, and through national retailers like Target, CVS, and Walmart.
Quali's SaaS-based platform engineering tools help enterprise DevOps and engineering teams optimize the continuous delivery of software at scale by enhancing developer productivity and improving cloud governance.
KANDOU specializes in the design of high-speed, and pin- and energy-efficient chip-to-chip links, SerDes, and associated technologies. Demand for bandwidth in serial links has increased as industries require both high-quantity and high-quality information. KANDOU BUS has developed a unique approach to serial link design that increases the bit-rate and the reach for a given physical communications link and reduces the power consumption. As a result, more bits can be sent per unit of energy, or less energy can be used to achieve a given bit rate. Less energy means available power can be used for more speed, greater battery life, smaller dies or novel designs that shatter many of today’s constraints. Their team of scientists and engineers, based in Switzerland, the UK, and the US, is pushing the boundaries of serial links.
Syte develops a product discovery platform designed to transform the way people search and shop online. It is a provider of visual AI technology that aims to improve retailers’ site navigation, product discovery, and user experience by powering solutions that engage and convert shoppers. The B2B enterprise's solution includes camera search, augmented site search, personalization engines, and smart in-store tools, empower shoppers to discover and purchase products instantly. Their camera solution enables shoppers to take a picture of a product that inspires them and search for visually similar products within a retailer’s site. Up to date, Syte has raised $71 million from investors including Viola Ventures, LG Tech Ventures, NHN Ventures, Kreos Capital, Naver Corporation, Commerce Ventures, Storm Ventures, Axess Ventures, La Maison, MizMaa Ventures, Magma, Naver Corporation, Line Corporation, Reimage Ventures, North Base Media, and KDC Ventures. In 2014, Helge Voss, Idan Pinto, Lihi Pinto Fryman, and Ofer Fryman established Syte in Tel Aviv, Tel Aviv.
Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control of their own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle. Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
Abivax is a clinical-stage biotechnology company, that mobilizes the body’s natural immune machinery to treat patients with autoimmune diseases, viral infections, and cancer. Their aim is to use Abivax's drug development platforms to provide novel and effective treatments to patients with large unmet needs in these therapeutic areas.
Bnext is a fintech platform headquartered in Madrid, Spain. Bnext is the first supermarket for financial products, it reflects a new way of banking that challenges traditional banking from its foundations. With Bnext users can do almost everything they do with a bank, without having to use a bank. It allows them to create their own current account in a matter of minutes, with nearly all the functionalities of an account in a traditional entity. Additionally, users can include their external accounts and hence have all their financial information on a single platform, regardless of the provider. However, the real innovation in Bnext lies on its Marketplace. Here, users have access to a wide range of financial products from fintechs and banks. The offering suplliers are meticulously selected in order to best fit the client's needs. On the platform, the user can scan through all different products, purchase them and control his acquisitions, all without ever leaving the app. Instead of charging the customer endless commissions and trying to sell as many products as possible, Bnext has developed a model that allows to really collaborate with the fintechs and get the best available offers on the market. The fintech portfolio to date includes real estate investment firms, mutual fund investment, loans and crowdlending, microloans or crowdfunding. Bnext is progressively integrating the most leading products in the market to expand the offer and thus become the first bank without balance.
ViCentra, they like to keep things simple. ViCentra believe that if products are simple, look beautiful and deliver superb results, they’ll be more enjoyable to use and more likely to help people achieve great things. Creating brilliant products doesn’t end at the manufacturing line though – they also believe in the power of great customer experiences. From our offices in the Netherlands and UK, they’re creating healthcare products with this philosophy firmly in mind. They don’t design for patients – they design for people.
Zerto provides business continuity software solutions to keep enterprise and cloud IT running 24/7. Through the Zerto Cloud Continuity Platform, organizations can protect and move virtualized workloads between public, private, and hybrid clouds. Its flagship product, Zerto Virtual Replication, allows users to protect, recover and migrate applications in the cloud and virtualized data centers. It was founded in 2009 and headquartered in Boston, Massachusetts.
smava, one of the credit comparison portals in Germany, continued the strong growth path of previous years in 2019: The brokered loan volume grew by 35% from around EUR 2 billion in 2018 to around EUR 2.7 billion. Likewise, smava grew again significantly in the first quarter of 2020: smava was able to increase the loan volume brokered by 45% compared to the same quarter of the previous year to approx. EUR 900 million. In total, smava has already brokered more than 8 billion euros in loans.
Scandit is a technology platform for mobile computer vision and augmented reality (AR) solutions for enterprises. The company software brings unrivaled scanning performance to any app on any camera-equipped smart device, from smartphones to wearables to drones and robots - to read barcodes, recognize text and objects, and display real-time information as AR overlays. It helps consumers and employees find things on store shelves with their smartphones, and as things become more contactless. Organizations in retail, transport, logistics, and manufacturing use Scandit to power apps such as mobile shopping, self-checkout, inventory management, proof of delivery, and asset tracking. Use cases in healthcare include tracking patients, medication, specimens, and supplies. Scandit solutions take cost and time out of operations and improve employee and customer satisfaction. Clients include 7-Eleven, Alaska Airlines, Carrefour, Hermes, Johns Hopkins Hospital, La Poste, Levi Strauss & Co, Mount Sinai Hospital, Sephora, and Toyota.
Inotrem S.A. is a biotechnology company specialized in immunotherapy for acute and chronic inflammatory syndromes. The company has developed a new concept of immunomodulation that targets the TREM-1 pathway to control unbalanced inflammatory responses. Through its proprietary technology platform, Inotrem has developed the first-in-class TREM-1 inhibitor, LR12 (nangibotide), with potential applications in a number of therapeutic indications such as septic shock and myocardial infarction. In parallel, Inotrem has also launched another program to develop a new therapeutic modality targeting chronic inflammatory diseases. Leveraging its proprietary technology platform, Inotrem has developed the first-in-class TREM-1 inhibitor, nangibotide (LR12), with applications in a number of therapeutic indications such as septic shock or myocardial infarction. Next to acute inflammatory syndromes, Inotrem is also developing a program targeting chronic inflammatory diseases.
Funnel is here to put an end to manual data collection. Funnel integrates with all marketing and advertising platforms and allows you to feed your data anywhere you want it. Out-of-the-box integrations with 400+ data sources. With Funnel, you will have the freedom to feed your data into any tool you like. Automatically feed data into your Business Intelligence tool, your Data Warehouse, Google Sheets, Google Data Studio, Google Analytics or any other visualization tool. Funnel caters to e-commerce companies, media agencies, brands, b2b businesses, mobile apps, and gaming companies. Fredrik Skantze and Per Made founded it in 2014. Offices in Stockholm (HQ) and Boston.
GenSight Biologics develops gene therapy-based treatments for retinal degenerative diseases. GenSight Biologics is a privately owned biopharmaceutical company, dedicated to the development and commercialization of gene therapy-based treatments of retinal degenerative diseases. Based on recent results obtained by the teams of its scientific founders, the company develops innovative approaches to prevent retinal degeneration in selected pathological conditions and to restore vision in patients suffering from very low vision or blindness.
VOI Technology is a micro-mobility startup that provides electric scooters for last-mile transportation. They create a system of electrically powered scooters around urban centers to provide a way to commute while helping people to reduce their carbon footprint and cities to have a more sustainable transportation network.
ACQUIRED IN 2023. Built to simplify employee onboarding and offboarding flows, Typelane is changing the way we welcome and say goodbye to our employees. With focus on smart workflows, intuitive design and personalisation Typelane transforms what once was manuell and complex process into an easy and engaging one.
MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic tests for cancer assessment and the personalized treatment of patients.
Neuromod is a medical device company formed to advance the science of bi-modal neuromodulation. We are committed to delivering treatments that significantly reduce the suffering of underserved patient populations who live with chronic and debilitating conditions globally. Our goal is to design products that empower patients to take control of their own treatment, delivering targeted therapies that integrate seamlessly into a modern lifestyle. Neuromod has developed and patented a bi-modal neuromodulation technology that it is evaluating for neurological disorders including chronic tinnitus, a condition affecting 10% of the adult population and commonly known as 'ringing in the ears'.
KANDOU specializes in the design of high-speed, and pin- and energy-efficient chip-to-chip links, SerDes, and associated technologies. Demand for bandwidth in serial links has increased as industries require both high-quantity and high-quality information. KANDOU BUS has developed a unique approach to serial link design that increases the bit-rate and the reach for a given physical communications link and reduces the power consumption. As a result, more bits can be sent per unit of energy, or less energy can be used to achieve a given bit rate. Less energy means available power can be used for more speed, greater battery life, smaller dies or novel designs that shatter many of today’s constraints. Their team of scientists and engineers, based in Switzerland, the UK, and the US, is pushing the boundaries of serial links.
BUX specializes in the fields of fintech, mobile apps, investments, stocks, and zero-commission. Its platform makes commission-free investing accessible, intuitive, and affordable for both first time and existing investors. It was founded in 2014 and headquartered in Amsterdam, Noord-Holland.
Gett Ltd. is a technology-based company that specializes in providing on-demand taxi and ground transportation services for businesses through its SaaS platform. Founded in 2010 and headquartered in Ware, United Kingdom, Gett enables clients to book corporate transportation services via a mobile application available on iOS and Android. The platform integrates various transportation providers, allowing businesses to manage their ground transportation expenses efficiently. With operations in key markets such as the United States, the United Kingdom, Israel, and Russia, Gett aims to simplify the corporate travel experience by offering features like automatic invoicing and detailed analytics, which can lead to significant cost savings. The company has also established a strategic partnership with The Volkswagen Group to enhance its service offerings.
Butternut Box is a UK-based startup, founded by two friends, Kev & Dave. Butternut Box focuses on offering fresh, human-grade dog food made from real ingredients. They prioritize the quality and nutritional value of their meals. The company offers a personalized approach to dog food by tailoring meal plans to meet the specific dietary needs and preferences of individual dogs. Customers can provide information about their dog's age, size, allergies, and dietary requirements, and Butternut Box creates a meal plan accordingly.
SuperSonic Imagine SA develops and manufactures ultrasound medical imaging systems for measuring and visualizing tissue elasticity. The company provides Aixplorer, an ultrasound system for breast lesion imaging; and ShearWave, an ultrasound technology platform for quantitative elastography. It offers its products through its offices and a network of distributors in France, Belgium, Austria, Croatia, Poland, the Czech Republic, Singapore, Taiwan, Thailand, Malaysia, Hong Kong, Lebanon, Germany, the United Kingdom, and the United States. SuperSonic Imagine SA was founded in 2005 and is based in Aix-en-Provence, France with additional offices in Germany, the United States, and the United Kingdom.
Quali's SaaS-based platform engineering tools help enterprise DevOps and engineering teams optimize the continuous delivery of software at scale by enhancing developer productivity and improving cloud governance.
Affluent Medical develops innovative new-generation mini-invasive implants to restore essential physiological functions in these areas: - Kardiozis aims to prevent endoleaks and risks of recurrence of the abdominal aortic aneurysm allowing patients to live more serenely facing an unpredictable risk of breakage; - Kalios and Epygon aim to provide more physiological surgical treatments for the repair or replacement of the mitral valve of the heart. Kalios can treat residual post-operative leakage and recurrent mitral insufficiency without having to reoperate patients. Epygon is today the only developing transcatheter valve to restore natural blood flow and safeguard the left ventricle. - Finally, Artus is the first electronically activatable artificial sphincter to treat stress urinary incontinence in men and women.
Planday bring down staff costs by 5%, reduce administration time by 75% and increase employee satisfaction by 20%. Planday is used by different sized companies in a variety of industries such as Restaurants, Hotels, Retailers, Call Centres, Fitness clubs, etc. Want to know more about Planday? Visit planday.com today.
Kiadis Pharma is a biopharmaceutical company focused on complications and limitations of hematopoietic stem cell transplants in blood cancer patients. The company has three blood cancer products in clinical development that offer novel treatment options for terminally ill cancer patients addressing high-unmet medical needs. Kiadis Pharma is headquartered in Amsterdam, The Netherlands.
Abivax is a clinical-stage biotechnology company, that mobilizes the body’s natural immune machinery to treat patients with autoimmune diseases, viral infections, and cancer. Their aim is to use Abivax's drug development platforms to provide novel and effective treatments to patients with large unmet needs in these therapeutic areas.
We're on a mission is to uncover the ‘unknown unknowns’ facing businesses today, highlighting the risks and opportunities so leaders can take effective action. Signal is a revolutionary technology platform built for analysing text and discovering market intelligence, developed in partnership with the world's leading academics. The AIQ aggregates, analyses, and provides business leaders with insights into digital, print and broadcast media, news, and regulatory data. Signal AI’s machine learning enables businesses to track their competitive landscape, changes to regulation, and monitor their reputation—empowering them to make smarter, faster business decisions. The company was founded in 2013 and is headquartered in London, England, United Kingdom.
BioCatch is the leader in Behavioral Biometrics which analyzes an online user’s physical and cognitive digital behavior to protect individuals and their assets. Our mission is to unlock the power of behavior and deliver actionable insights to create a digital world where identity, trust and ease seamlessly co-exist. Leading financial institutions around the globe use BioCatch to more effectively fight fraud, drive digital transformation and accelerate business growth. With over a decade of analyzing data, over 60 patents and unparalleled experience, BioCatch continues to innovate to solve tomorrow’s problems. For more information, please visit www.biocatch.com
Our mission is to help everyone in the UK better understand their pension(s), allowing them to be more informed and ultimately better off in retirement. We provide impartial, expert and ongoing pension advice. You don’t need to be financially savvy to be our customer. You don’t need to be ‘high net worth’. You don’t even need to know anything about your pension. All you need is to want to do something about your financial future. We can help with the rest.
Currencycloud is a global payments platform built on smart technology that takes the complexity out of moving money. Developers use their API building blocks to build customized payment solutions. Whether you want to embed their payments infrastructure into your products or services, or build on top of it, they will fit into your business in a way that works for you. They take care of all the intricacies and regulatory hurdles involved with cross-border payments, giving you the tools to globalize your business.
Mereo is based in London and was founded in March 2015 to fund and develop novel, innovative specialist focused products from large pharmaceutical or biotechnology companies. Pharmaceutical companies face increasingly difficult choices in the allocation of internal resources to their drug development programs. With significant P&L constraints and rich pipelines it has become increasingly difficult for many companies to fully fund and advance development all of their drug candidates, especially beyond Phase 2. Mereo has been formed to take advantage of the global pharmaceutical industry's drive for creative ways to progress their clinical development pipelines. Mereo has acquired an initial mid-late stage portfolio of three exceptionally well characterised novel products for the treatment of diseases with considerable unmet medical need from Novartis Pharmaceuticals. Each of these programmes has a comprehensive dataset for both pre-clinical and proof-of-concept clinical studies. Additional product opportunities are under evaluation. Mereo's focus is the development of innovative medicines that have the potential to significantly transform the lives of patients suffering from rare and other specialised conditions around the world. To do this, the Company depends on the combination of its team's expertise in selecting and acquiring product opportunities, creating value in the development pipeline and structuring creative transactions. Mereo's internal expertise is complemented by a unique partnership with a leading global CRO, ICON. Mereo combines the operational discipline and efficiency of a small company with the financial resources to conduct comprehensive clinical studies. Mereo will rapidly progress each of the products through further value inflection points before partnering or divesting its products. The Company also has the option to directly commercialise products, for example in orphan disease indications.
Kiadis Pharma is a biopharmaceutical company focused on complications and limitations of hematopoietic stem cell transplants in blood cancer patients. The company has three blood cancer products in clinical development that offer novel treatment options for terminally ill cancer patients addressing high-unmet medical needs. Kiadis Pharma is headquartered in Amsterdam, The Netherlands.
Puls is a venture-funded startup that powers a nationwide network of service providers in delivering home services. It offers a wide variety of handyman services, appliance repair services, TV mounting, and disinfection services. Puls handyman services include but aren’t limited to furniture assembly, wall hanging including shelf installation, drywall repair, interior painting, appliance installation, and fan installation. The company was founded in 2015 and is headquartered in San Francisco, California.
We're on a mission is to uncover the ‘unknown unknowns’ facing businesses today, highlighting the risks and opportunities so leaders can take effective action. Signal is a revolutionary technology platform built for analysing text and discovering market intelligence, developed in partnership with the world's leading academics. The AIQ aggregates, analyses, and provides business leaders with insights into digital, print and broadcast media, news, and regulatory data. Signal AI’s machine learning enables businesses to track their competitive landscape, changes to regulation, and monitor their reputation—empowering them to make smarter, faster business decisions. The company was founded in 2013 and is headquartered in London, England, United Kingdom.
Cellnovo Group SA is a medical technology company based in Paris, France, that focuses on developing and marketing innovative mobile diabetes management systems. Its flagship product includes a cordless micro-pump for insulin administration, an integrated activity monitor, and a cellular-enabled wireless touchscreen handset that connects securely to servers for real-time data access. This system allows users to manage insulin injections effectively while enabling family members and healthcare professionals to monitor the patient's condition remotely. The company aims to empower individuals with diabetes by providing tools that simplify management and enhance their quality of life. Cellnovo markets its products through a direct sales force in the United Kingdom and France, as well as through international distributors. Additionally, it has partnered with Diabeloop SA to develop an artificial pancreas solution, further expanding its commitment to innovative diabetes care. The company was incorporated in 2014 and seeks to transform diabetes management through thoughtful design and modern technology.
TME Pharma is a biopharmaceutical company, develops biostable aptamers and substances based on mirror image nucleic acids. Its Spiegelmer is a mirror image oligonucleotide therapeutic for the pharmacologically relevant target. The company has a strategic alliance with Pfizer, Inc. NOXXON Pharma AG was founded in 1997 and is based in Berlin, Germany.
ROLI is a music technology firm. Their products include hardware, software, sounds, and accessories. They make the process of learning and practicing music possible. Their team of musicians, programmers, teachers, anthropologists, engineers, and artists is reimagining music learning and music creation through hardware and software. They design, develop, and manufacture music-making devices.
Proveca Ltd is a pharmaceutical company specialising in identifying, researching and licensing off-patent medicines with unmet priority health care needs, with a focus on the paediatric market. By developing the necessary formulations and clinical data required to obtain a Paediatric Use Marketing Authorisation (PUMA) these drugs will benefit from a period of 10 years' market protection (8 years of data and market protection plus 2 further years of market protection). In addition, where appropriate, Orphan Drug status (Orphan Drug) will be sought which affords a period of 10 years' market exclusivity to run concurrently. Value will be realised through commercialisation of the licensed medicine or an outright sale of the licence to a larger pharmaceutical company.
SoundCloud is a social sound platform where anyone can create and share sounds. It allows people to discover and enjoy the largest selection of music from the world’s most diverse creator community. This is made possible by an open platform that directly connects creators and their fans across the globe. Sound creators can use the platform to instantly record, upload, and share sounds across the internet, as well as receive detailed stats and feedback from the SoundCloud community. SoundCloud was launched in 2008 by Alexander Ljung and Eric Wahlforss.
Teridion is a superior cloud-based global connectivity platform. Teridion's network has over 500 points of presence worldwide and works with over 25 public clouds to ensure a stable, high performance connectivity anywhere (including mainland China!). The WAN as a service solution works with any edge device and is easy to scale and set up, with no hardware or software required. Teridion's solutions fit global enterprises and SaaS companies. Its interoperability makes it the perfect solution to integrate with additional backend solutions, as well as security ones. Teridion handles middle-mile issues (core network issues) to ensures that routes are always performing at maximum optimization, bringing you up to 20X more throughput versus public Internet.
CrossLend designs a cross-border marketplace lending platform that makes pan-European investments possible via a single platform. The company's platform connects private and institutional investors from low-interest rate countries with borrowers from high-interest rate countries and intermediates loans and securitizes them into bonds in which they can invest, enabling investors with attractive risk-return profiles and borrowers with attractive interest rates.
BONESUPPORT is a medical technology company dedicated to the development of injectable osteoconductive biomaterials for the treatment of fragility fractures caused by osteoporosis, and bone voids or gaps caused by trauma, disease or related to surgical procedures. The company's mission is to restore health to enhance the quality of life for patients with bone disorders. BONESUPPORT was founded on 2000 and is headquartered in Lund, Sweden.
EPS operates in the sustainable energy sector, specializing in hybrid-storage solutions and microgrids that enable intermittent renewable sources to be transformed into a stable power source. Listed on the French-regulated market Euronext (EPS:FP), EPS is part of the CAC® Mid & Small and the CAC® All-Tradable indices and has registered office in Paris and research, development and manufacturing in Italy. Thanks to technology covered by 125 patents and applications, combined with more than 10 years of R&D, the Group has developed hybrid energy storage solutions to stabilize electrical grids heavily penetrated by renewable sources in developed countries and, in emerging economies, to power off-grid areas at a lower cost than fossil fuels without the need for any subsidy or incentive scheme. EPS has installed and has under commissioning in aggregate 36 large scale projects, including off-grid hybrid systems powered by renewables and energy storage totalizing over 35 MW of installed power that provides energy to over 165,000 customers every day, in addition to more than 18 MW of grid support systems, for a total capacity output of 47 MWh of systems in 21 countries worldwide, including Europe, Latin America, Asia and Africa.
Pixium Vision is developing retinal implant systems for patients who have lost their sight, with the intention of improving their vision and enabling them to lead more independent lives. The Company intends to harness the rapid advances being made in neural processing, micro-electronics and computing to develop retinal implant systems that for blind people could ultimately provide vision approaching that of a normal healthy Pixium's first device, IRIS1 (Intelligent Retinal Implantable System), uses an epi-retinal implant (on the retinal surface) and is currently in clinical trials with the goal of obtaining CE Mark. A second generation system (IRIS2) based on the same format, but offering better visual acuity and featuring several breakthrough technologies, is also under development. In addition, Pixium is developing a sub-retinal implant system (IRIS3), based on further technological breakthroughs, which has the potential to improve vision significantly compared to IRIS1 and IRIS2. Pixium was created in Paris, France in November 2011 as a spin-out of the Vision Institute and Université Pierre et Marie Curie, and based on collaborative work involving several leading academic teams across Europe. Pixium is backed by a syndicate of blue-chip European venture capital firms including Sofinnova Partners, Omnes Capital, Abingworth, Global Life Sciences Ventures, Seventure and Polytechnos.
Since 2012 Reduxio has redefined data management and data protection, and the company has evolved its mission to deliver the first microservices-based storage and data platform for stateful applications. Reduxio’s cloud data platform for Kubernetes pairs high performance software-defined container-native storage and data management with data mobility to enable customers to build a single data cloud for their applications across all their infrastructure, anywhere. Reduxio is backed by Intel Capital, C5 Capital Cloud Partners and Jerusalem Venture Partners (JVP).
Searchmetrics is a global provider of search data, software and consulting solutions. Its innovative approach ensures household names like AXA, Lowe’s and McKinsey & Company thrive in the hyper-competitive search landscape. Searchmetrics enterprise offerings turn data from search into unique business insights that fuel clients’ continued growth. Searchmetrics Suite delivers data-driven insights to maximize search and content performance. Its four modules: Research Cloud, Content Experience, Search Experience and Site Experience contain the tools SEO professionals, content marketers and digital specialists need to grow their organic search into a major driver of revenue. The Digital Strategies Group is a team of data, SEO and content consultants who guide the world’s largest brands to excellence in digital marketing. Searchmetrics Insights offer new sources of market research through exclusive metrics and analysis derived from search data. Searchmetrics API allows enterprises to enrich BI or data warehouse applications with search engine rankings, keywords, content data and other marketing analytics.
Zooz is a technology company that provides a payments platform designed to help merchants maximize their payments performance. The company was established in 2010. In July 2018, Zooz was acquired by PayU.
Based in Berlin, Germany, Savedo is a European online marketplace for retail investment products that ensures safely deposited savings and better interest rates across the European Union. The platform supports the involved banks by handling their customer services and providing standardized account documents. Savedo enables its clients to easily invest across Europe without having to travel to the respective European country. Launched in 2014, Savedo’s team is comprised of experienced international finance specialists and online professionals.
Marley Spoon makes meals at home by sending recipes and ingredients directly to the door. They provide recipes to help customers in ordering ingredients. They specialize in meal delivery services.
Mobile Widespace is an advertising company that sells ads over mobile devices. The company was founded in 2007 by Patrik Fagerlund and Henric Ehrenblad.
Lifeward develops, manufactures, and markets a walking system for persons with lower limb disabilities Its products include ReWalk Rehabilitation System and ReWalk Personal System. ReWalk Rehabilitation System allows walking, standing, sitting, and the capacity to ascend or descend stairs in the rehab center environment. The ReWalk Personal System is designed for everyday use in a range of environments. It can be used at home, work, or other locations and it functions outdoors and on different surfaces or terrains. The ReWalk Personal System allows sitting, standing, and turning as well as offers the ability to climb and descend stairs. The company changes the quality of life for individuals with lower limb disability by developing robotic technologies. Rewalk Robotics was founded on 2001 and is based in Marlborough, Massachusetts.
Headquartered in Dublin, Ireland, ChannelSight's leading technology creates a swift and seamless path to purchase to help consumers buy the products that they are interested in easily and efficiently. ChannelSight's in-depth metrics help you plan ahead your online eCommerce strategy & monetize digital channels to give your consumers a leading user experience. Our products, that you can combine, or use as stand-alone products, including: Where To Buy Technology, Add To Cart Function Dynamic, Social Feed, eTail Monitoring & Offline Locator. With our solutions, you can understand every customer journey and drive sales on every retailer site. Because when you know more, you sell more.
Blackwood Seven is a media analytics platform which strives to increase the effect of company’s media spend using our predictive analytics framework built on machine learning and artificial intelligence. Using real-time modelling and advanced KPI prediction we are able to increase a company’s media ROI by up to 15-25%.
Rockley is developing a comprehensive range of photonic integrated circuits and associated modules, sensors, and full-stack solutions. From next-generation sensing platforms specifically designed for mobile health monitoring and machine vision to high-speed, high-volume solutions for data communications, Rockley is laying the foundation for a new generation of applications across multiple industries. Rockley believes that photonics will eventually become as pervasive as micro-electronics, and it has developed a platform with the power and flexibility needed to address both mass markets and a wide variety of vertical applications.
CropX, an ag-analytics and IOT company, develops AI-driven, cloud-based software solutions integrated with data from proprietary and 3rd-party sources, boosting crop yield (up to 15%)and saving water (up to 50%), pesticide use (up to 20%), fertilizer use (up to 20%), with energy and labor savings as well. It offers a comprehensive solution on one platform to help farmers achieve successful and sustainable results in the complex growing environment. The system is trusted and easy to use with global deployments on over 5,000 farms in 70 countries, and quickly growing. Partnerships and connections with key industry players, such as Reinke, Syngenta, PepsiCo, Helm, NEC, John Deere, Climate FieldView, and many others, make it easy for farmers to automate operations, and share data across systems.
LiquidM’s modular cloud-based software allows agencies and trading desks to run their ad tech infrastructure on a standardized, open platform that is customizable to their individual needs. LiquidM uniquely combines media, data, technology, and strategy to allow the audience to reach scale. LiquidM provides more efficiency, greater control, and deeper insights into media planning and buying, to drive better results. Integrated data management, audience targeting, and inventory procurement drive success in the mobile display media marketplace.
Sckipio Technologies specializes in Gfast technologies. The company is passionate about delivering ultra broadband access for the masses. It is the first semiconductor company focused on the exciting new ITU standard. Sckipio is the first company to deliver Gfast modems and the only company with award-winning Gfast technology. More than 20% of the Gfast standard came from Sckipio technical contributions. The company was founded in 2012 and is headquartered in Ramat Gan, Israel.
Thread operates as an online personal styling platform designed to help men find clothes. The platform offers a combination of human stylist and machine learning algorithms, where they receive personalized information from human stylists and suggestions from an algorithm that understands the customer's preferences over time, helping men to dress well without having to go shopping.
The Novacyt Group is a rapidly growing, international diagnostics business generating an increasing portfolio of in vitro and molecular diagnostic tests. Its core strengths lie in diagnostics product development, commercialisation, contract design and manufacturing. The Company’s lead business units comprise of Primerdesign and Lab21 Products, supplying an extensive range of high quality assays and reagents worldwide. The Group directly serves oncology, microbiology, haematology and serology markets as do its global partners, which include major corporates.
Artesian is a powerful technology for client facing commercial teams, designed to accelerate revenue growth by helping create deeper and more meaningful B2B relationships. Artesian has invested over a decade creating leading technology which can read and interpret millions of sources of unstructured content published online which it can combine with factual data about companies. The resulting powerful insights and triggers are used to create meaningful conversations to drive engagement and better long-term customer relationships. Artesian’s usage and adoption rates are some of the highest in the software industry with a browser, mobile device and integrated CRM user-experience. Artesian ENGAGE helps sales and customer facing teams create genuine relationship-based customer experiences by providing them with a suite of tools to find, get to know, engage, sell and retain. For companies in regulated industries, Artesian’s Risk and Compliance Hub (ARCH) uses a sophisticated fully programable and configurable decision engine to continuously monitor real-time credit risk and KYC data sources, applying a company’s own internal policies to immediately flag potential issues so they can be resolved by the front-line teams who are best placed to engage with the client.
Crocus Technology SA provides magnetic random access memory products and technologies for the semiconductor and electronic systems industries. It offers its products for use in telecommunication, networking, storage, computing, and handheld applications.
Auctionata | Paddle8 is an online auction platform specializing in art and luxury collectibles. As of February 29, 2017, Auctionata has announced it has ceased operations, declaring insolvency. The company had offices in Berlin, New York, London, Los Angeles, Rome, Zurich, and Madrid. Following the conclusion of its preliminary insolvency proceedings on February 28, 2017, Auctionata Paddle8 AG ceased its German operations. The subsidiaries Paddle8 in the US and Value-my-Stuff in the UK were sold and continue to operate.
Spotcap empowers SMEs with tailored finance, allowing them to focus on their business. The company operates as a direct lender to SMEs in the United Kingdom, the Netherlands, Spain, Australia and New Zealand where they offer promising businesses access to flexible finance. Spotcap’s online application is straightforward and can be completed in as little as five minutes, either online or in collaboration with a financial advisor, broker or accountant. Spotcap was founded in 2014 and is headquartered in Berlin.
ToucanBox delivers packages of educational and inspirational activities that are suitable for children. It offers a box of stimulating, educational, and inspirational activities to children aged 3-8. Each box is put together by educational experts to help motivate and engage children, as well as develop key skills essential to a child's progression. Every toucanBox includes all the materials required to create 1,2 or 4 projects, a set of easy-to-follow instructions and a reading book to encourage children to investigate a variety of topics. A new theme is delivered to the child monthly or bi-weekly, bursting with fresh ideas to inspire children.
Adbrain powers marketers and their partners to understand and engage with their customers 1:1 across devices, channels and platforms.
myTomorrows is an independent, globally operating organization based in the Netherlands. We provide patients with unmet medical needs, and their doctors, information about treatment options worldwide and facilitate access to medicines in development. Our goal is to ensure that patients and doctors don’t miss out on treatment options due to lack of information, understanding and administrative hurdles. Working together with medicine manufacturers to devise and execute strategies for early access, we strive to make it easier for doctors and their patients who ran out of viable treatment options to find, get information about and access to medicines in development. myTomorrows has developed a Knowledge Base to combine vast amounts of medical and clinical data to present an actionable overview of the full clinical development pipeline.
Dreamlines GmbH, founded in 2012 and headquartered in Hamburg, Germany, is an online travel agency specializing in cruise-related travel. The company provides a diverse array of cruise options, including family, river, luxury, and mini cruises, as well as packages for singles and round trips that can include flights. Dreamlines has established itself as the largest cruise portal in Europe and is rapidly expanding its global presence, operating in 12 countries across five continents. With over 600 dedicated employees, it focuses on enhancing customer satisfaction through a proprietary GDS/CRM system tailored to the unique needs of the cruise industry. The company also offers exclusive cruise packages designed by experienced cruise experts, further solidifying its position as a leading player in the online cruise booking market.
Riskified empowers businesses to realize the full potential of eCommerce by making it safe, accessible, and frictionless. We have built a next-generation platform that allows online merchants to create trusted relationships with their consumers. Leveraging machine learning that benefits from a global merchant network, our platform identifies the individual behind each online interaction, helping merchants—our customers—eliminate risk and uncertainty from their business. We drive higher sales and reduce fraud and other operating costs for our merchants and provide superior consumer experiences, as compared to our merchants’ performance prior to onboarding us.
Poxel is a dynamic biopharmaceutical company developing innovative drugs for metabolic diseases, with a focus on type 2 diabetes and non-alcoholic steatohepatitis (NASH). Based in Lyon, France, Poxel was spun out in 2009 from Merck Serono, a global leader in the field of metabolic disorders at that time. They believe that targeting cellular energy regulation pathways for the treatment of metabolic diseases, including type 2 diabetes is of critical importance as disbalances are at the root of those diseases. All three of their clinical stage pipeline programs address significant targets in the energy metabolism pathways. Imeglimin, their lead program, targets mitochondrial dysfunction, mitochondria being the power station of the cell, PXL770 activates the adenosine monophosphate-activated protein kinase (AMPK), an important energy sensor, and PXL065 (DRX-065) inhibits the mitochondrial pyruvate carrier (MPC).
Bluevine is on a mission to enable a better financial future for small business owners through innovative banking solutions designed just for them. By combining industry-leading technology and security with our team's expertise and care, we help small businesses spend their time on what matters most—the next chapter of their business. As a dynamic company with massive potential, we’re backed by leading investors such as Lightspeed Venture Partners, Menlo Ventures, 83North, Citi Ventures, and nearly 9 years of proven success. Since launching in 2013, we have grown exponentially, amassing over 400,000 customers across all 50 states and providing more than $13 billion in financing to small businesses. Our passion is driven by purpose: to give small businesses the tools they need to succeed and we’re just getting started.
Inneractive is a leading independent mobile ad exchange focused on powering native and video ads. Their mission is to empower mobile publishers to realize their properties’ full potential by providing powerful technologies for the buying and selling of mobile ads. Inneractive is headquartered in Tel Aviv with offices in San Francisco, New York and London.
Monedo Holding GmbH specializes in providing credit lending solutions through advanced technology, particularly focusing on the underbanked population. The company employs machine-learning algorithms and big data scoring to enhance credit decision-making and accessibility. Its product lineup includes customized installment loans, microloans through Kredito24, a digital wallet, and a personal finance manager aimed at helping customers manage their finances effectively. Additionally, Monedo offers a "Lending as a Service" model, enabling partners to integrate its credit products via API into their platforms. Founded in 2012 and headquartered in Hamburg, Germany, Monedo operates across multiple markets, including Poland, Romania, Russia, Spain, and Thailand, processing over four million loan applications to date. The company is led by CEO and Co-Founder Alexander Graubner-Müller and is supported by prominent investors.
Delivery Hero is a worldwide network of online food ordering sites, operating in 21 countries and with over 73,000 restaurant partners. Delivery Hero operates in Germany, UK, Austria, South Korea, Sweden, Finland, Poland, Australia, Switzerland, China, India, Colombia, Mexico, Argentina, Chile, Uruguay, Brazil, Peru, Venezuela, Panama, and Puerto Rico. The Group has more than 1000 employees globally, with 400 working from its Berlin Headquarters. Delivery Hero has received $523 million in investment in 2014 alone with investors including Insight Venture Partners, Luxor Capital Group, Kite Ventures, Team Europe, ru-Net, Tengelmann Ventures, Point Nine Capital, Vostok Nafta, and Phenomen Ventures.
TiGenix NV (TiGenix) and its subsidiaries TiGenix Inc. and TC CEF LLC. is a Belgium-based biomedical company that focuses on innovative local treatments for damaged and osteoarthritic joints. The Company is exploiting the power of regenerative medicine for the development of durable treatments, validated through controlled clinical studies, for these indications. TiGenix is located in Leuven and was founded as a spin-off of the Catholic University of Leuven and the University of Ghent. TiGenix is developing a portfolio of products that addresses specific musculoskeletal problems. The lead indication among these is cartilage damage, which is a debilitating affliction severely affecting the mobility and functioning of patients. During the fiscal year ended December 31, 2009, the Company acquired Orthomimetics Ltd.
StrikeAd Fusion, a proprietary technology platform for agencies and advertisers to plan, execute, and evaluate their mobile advertisements. It is created to answer the ever growing need of media planning and buying agencies to manage their mobile campaigns effectively through a single platform. The company's platform is not a bolt on to an existing DSP but a mobile-specific platform in its own right, a single console through which agencies can plan, execute and evaluate hundreds of mobile campaigns, minute-by-minute, on a global basis.